你即將離開本站

並前往https://www.healio.com/news/pulmonology/20191001/inbuild-nintedanib-slows-progression-of-fibrosing-ild

INBUILD: Nintedanib slows progression of fibrosing ILD - Healio

In the double-blind, placebo-controlled phase 3 INBUILD trial, Kevin R. Flaherty, MD, from the division of pulmonary and critical.

確定！ 回上一頁

查詢 「INBUILD trial」的人也找了：

  1. INBUILD trial
    2.
  2. SENSCIS trial
    3.
  3. Nintedanib clinical trial
    4.
  4. pf-ild definition
    5.
  5. Pirfenidone
    6.
  6. TOMORROW trial
    7.
  7. RELIEF pirfenidone
    8.
  8. Progressive fibrosing interstitial lung disease
    9.